Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
Levothyroxine sodium is a synthetic thyroid hormone replacement therapy administered intravenously as a solution. It is indicated for thyroid hormone replacement in hypothyroidism and related thyroid disorders. The drug works by supplementing or replacing insufficient endogenous thyroid hormone production.
Product is in peak lifecycle stage with moderate competitive pressure (15 competitors), suggesting stable team sizing and focused commercial execution on market consolidation.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form
Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation
Working on levothyroxine sodium offers stable, established-product experience in a high-volume, peak-stage commercial environment. Career growth will center on operational excellence, market consolidation, and preparing for eventual LOE rather than on novel mechanism innovation or expansion indications.
Worked on LEVOTHYROXINE SODIUM at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo